Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Rheumatoid Arthritis Treatment Linked with Lower Dementia Risk
1
Mins
May 2024
A new study found that, among patients with rheumatoid arthritis who are treated with biologic disease-modifying antirheumatic drugs, dementia risk is decreased.
Read more
1
Mins
18th July 2016
Hip Surgery May Not Be Best Choice
EVIDENCE from a study carried out in the USA shows that arthroscopic hip surgery might not always be a suitable option for people with osteoarthritis…
1
Mins
18th July 2016
Adalimumab Drug Suppresses Inflammation in Rheumatoid Arthritis Patients
DISCOVERY of a new function in a widely used anti-inflammatory drug could offer new insight into the divergent efficacies of different medications which…
4
Mins
17th June 2016
New Data Presented at the Annual European Congress of Rheumatology (EULAR 2016) Demonstrate Safety and Efficacy of Biogen’s Anti-TNF Biosimilars Portfolio
June 09, 2016 07:08 AM Eastern Daylight Time ZUG, Switzerland–(BUSINESS WIRE)–Data demonstrating long-term comparable efficacy, safety and immunogenicity…
4
Mins
10th June 2016
New Data Demonstrates Sandoz’ Etanercept and Rituximab Biosimilar Candidates Bioequivalent to Originator Products
Holzkirchen, June 9 2016 – Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from two key studies…
3
Mins
2nd June 2016
Artificial Hip Joints and Obesity: Risk of Complications Rises with BMI but Benefits Predominate
Geneva, 2 June 2016 – Every tenth patient who receives an artificial hip joint in Europe is obese. This is a big challenge for orthopaedic surgery…
1
Mins
31st May 2016
Introducing EMJ Hepatology 4.1
United Kingdom, May 31, 2016: Welcome to the latest edition of EMJ Hepatology, which provides a collection of articles on the latest hepatology research…
1
Mins
23rd May 2016
Novel Computational Model Simulates Long-Term Osteoarthritic Risk
DEGENERATION rates of joint cartilage over time have been accurately predicted using a newly developed computer simulation model, researchers have…
2
Mins
15th April 2016
EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases
Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…
Loading posts...
« Previous
1
…
12
13
14
15
16
Next »